Pierre-Louis Bardonnet. Pharm.D., Ph.D. Email & Phone Number

Bagsværd, DK

• Principal Scientist:
• Subject matter expert for oral formulation of macromolecules (proteins, peptides, nanobodies, affibodies, semaglutide, insulin, GLP-1 analogue) containing or not permeation enhancers, with focus on diabetes, obesity.
• Participate in projects progression with a highly business strategic fit, global mindset and cross-functional focus.
• Design, execute and conclude on experiments in alignment with project plans and results.
• Collaborate with and supervise laboratory Technicians.Project Manager of Oral Formulation project for delivery of macromolecules:
• Direct management of 10 team members and transversal management of numerous FTE trough Analytical, Characterization, Pharmacology, Large animals, Histopathology, Screening and Bioassay departments.

Brentford, Middlesex, GB

• Lead complex global projects across multiple areas for the “Pain Relief” products, from product conception to commercialisation (End-to-End process). Accountable for Analytical, Formulation, Manufacturing, Environment.
• Lead a team of R&D Scientists as well as Regulatory, CMC, Medical Affair, Clinical and Safety. Manage overall work priorities and ensure team activities are in accordance with company standards and regulations, taking.
• Managed a world-wide team (13 people in 5 countries) for the launch of a fixed-dose combination of oral solid dosage form, across multiple functions.
• Led a team of experts, including external partner (7 people in 4 countries) to develop a fast disintegrating direct compressible paracetamol tablet (Panadol Advance®) aiming to save up to 40% of manufacturing cost..
• Supported and coached less experienced team members, both in their day to day operations and development plans. Gave more than 10 courses on pharmaceutical technologies.

St. Gallen, Switzerland, CH

• Besides formulation scientist activities:
• Lead project teams for technical projects; interact and coordinate project activities with internal and external stakeholders; schedule timelines and project development activities according to the company goals.
• Provide support to regulatory, CMC, quality, production and process validation according to current regulatory requirements.Key achievements:
• Successfully led the scale-up (4 & 5 times increase) and technical transfer for freeze-drying and sizing processes of 2 biological products (Uro-Vaxom® & Broncho-Vaxom®).
• Developed and registered (in Switzerland & Turkey) a tablet obtained by direct compression (Doxium 1000®).
• Led a 5 years project involving 3 sites and 7 departments, allowing the company to secure critical business with climatic zone IVb countries.

Meyrin, Geneva, CH

- In charge of formulation for various pharmaceutical dosage forms.- Responsible of pre-formulation, formulation, development and optimization of the manufacturing process. - Primary packaging selection.- Preparation and reviewing of SOPs, protocols, CTD and scientific reports.- Preparation and monitoring of stability protocols according to ICH.

Villeurbanne, FR

- Lecturer and teacher for the pharmaceutical technology practical labs for undergraduates. - Ph.D. Thesis: "Formulation and characterization of synthetic glycolipids-loaded liposomes to target Helicobacter pylori”.- Liposomes formulation.- Physico-chemical characterization of synthetic glycolipids-loaded liposomes. - Helicobacter pylori characterization.

Villeurbanne, FR

Ph.D.Thesis

Leading Digital Business Transformation

Ph.D., Pharmacy

Ph.D., Pharmacy

Dea/Master, Pharmacotechnie Et Biopharmacie

Pharm.D., Pharmacy

Master'S Degree, Biomedical & Medical Science